Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
This VJOncology podcast episode discusses the evolving treatment landscape of advanced NSCLC, referencing ELCC 2026. It covers precision oncology, rare alterations, emerging targeted agents, first-line sequencing, and new immunotherapy classes, with insights from clinicians on…